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Abstract 
Due to its unique properties, gold nanorods (AuNR) have been widely studied for diverse 
biomedical applications such as drug delivery, biosensing, bioimaging and photothermal 
therapy. However, as-prepared AuNR are known to be cytotoxic, due to the presence of the 
surfactant cetyl trimethylammonium bromide (CTAB). Bearing this drawback in mind, before 
use AuNR for biomedical purposes it is thus necessary to modify particles surface, making 
them more biocompatible and stable under biological conditions. Functionalization of AuNR 
with natural-based polymers that are biodegradable and biocompatible can be envisioned to 
circumvent the cytotoxicity issues, while enable the controlled release of drugs/bioactive 
agents. Herein, natural and biocompatible low acyl gellan gum (GG) was used for the first 
time to coat AuNR, previously modified with poly(acrylic acid sodium salt) (PAA) and 
poly(allylamine hydrochloride) (PAH). Transmission electron microscopy (TEM) images confirm 
the presence of a GG shell around individual particles, with an average size of 6.8 nm. GG-
coated AuNR (AuNR-(PAA PAH GG)) display an increased stability in a wide range of pH and 
ionic strength conditions, when compared to the as-prepared and polymeric modified AuNR, 
as determined by UV-Vis spectroscopy. Particles biocompatibility was also analysed in vitro by 
means of performing a MTS assay, and no significant cytotoxicity was found for AuNR-(PAA 
PAH GG) after 14 days of incubation with both SaOS-2, a human osteoblast-like cell line, and 
rabbit adipose stem cells. Dark-field microscopy and TEM have shown that internalization of 
AuNR-(PAA PAH GG) occurs on both cell types and that particles stay aggregate inside cells, 
but in different intracellular structures. With the final aim of using these particles as drug 
delivery systems for bone tissue engineering, we attempted the encapsulation of 
dexamethasone onto AuNR-(PAA PAH GG). However, further work is needed to optimize the 
loading process and drug quantification. 
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Chapter 1 
Introduction 
1.1. Gold Nanoparticles 
Metal nanoparticles exhibit unique physicochemical properties, different from the 
corresponding bulk material, which are a direct consequence of the quantic effect [1]. Among 
the different types of metal nanoparticles, gold nanoparticles (AuNP) have arisen a lot of 
interest between researchers of different fields [2]. Drug delivery, biosensing, bioimaging and 
photothermal therapy are some of the areas where these particles can be applied [2–7]. 
Along with its straightforward synthesis process and easy functionalization, AuNP outstand 
from the other metallic counterparts because of their non-toxic nature and biocompatibility. 
Furthermore, these particles offer a multitude of advantages for biological applications [6, 
8]. Firstly, one can consider the ability to tune size and shape of particles in a wide range. 
Gold nanoparticles can be synthesized with different shapes namely, spheres [9], rods [3, 5, 
7], cages [4] and star-like [10]. The high surface to volume ratio provides an efficient loading 
of multifunctional moieties and enhances solubility and stability of the loaded drugs, which is 
desirable for therapeutic approaches.  
Similarly to other noble metal nanoparticles, AuNP can absorb light of several 
wavelengths due to the formation of plasmon resonances on their surface. These surface 
plasmon resonances (SPR) represent the collective oscillation of the conduction electrons, 
caused by the resonant excitation via the incident photons. The surface electron density is 
polarized to one side as the wave front of light passes, leading to a standing oscillation in 
resonance with light frequency [11]. The intensity and wavelength of SPR bands are directly 
influenced by particle size and shape, the solvent, surface ligand, core charge, temperature 
and proximity of other nanoparticles [11–13]. AuNP also have the capability to convert the 
absorbed light into heat. In this sense, AuNP can be used as cell imaging label and as photo-
thermal agent for controlled drug release and/or cancer ablation by hyperthermia [14]. The 
possibility to combine those advantages in a single device paves the way for the development 
of theranostic nanoscale systems. 
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1.1.1. Gold Nanorods 
Anisotropic gold nanorods (AuNR), as an alternative to spherical nanoparticles, display 
two different SPR bands, one related to their width - transverse SPR band - and the other 
related to length, the longitudinal SPR band (LPB) (Figure 1). While the first appears near 500 
nm, and does not depend on the aspect ratio of NP, the wavelength of the LPB can be tuned 
according to AuNR size and aspect ratio [11]. As the aspect ratio (length divided by width) 
increases, an increase on intensity and wavelength maximum of the LPB is noticed. Then, this 
band can be anywhere from the visible (600 nm) to the near Infra-Red (NIR) (>1100 nm) [15]. 
The capacity of absorbing in the NIR zone is extremely useful for biomedical and regenerative 
medicine applications because NIR light has minimal absorption by skin and tissues. 
Therefore, it allows the development of devices with deeper tissue penetration and minimal 
tissue invasion [14, 16], namely for hyperthermia therapy and drug/gene delivery [5] and NIR-
resonant biomedical imaging modalities [14]. These includes two-photon luminescence 
imaging [4, 17, 18], photoacoustic tomography [16, 19], optical coherence tomography [20–
22] and X-ray computed tomography. 
 
 
 
 
 
 
 
 
 
 
 
Hence, as other shapes of AuNP, AuNR can be used for a multitude of imaging and 
therapeutic modalities. These can be fused in one single system to combine both therapeutic 
and diagnostic capabilities, following the concept of theranostics. Moreover, the possibility to 
remotely mediate the functional modalities by NIR-light confers to AuNR an exceptional 
advantage over other nanoparticle-based theranostic platforms. 
 
 
Figure 1 – Typical UV-Vis spectrum of AuNR, with schematic representations of SPR in AuNR. 
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Gold Nanorods Synthesis 
In terms of NP synthesis, the kinetically and thermodynamically favourable morphology is 
the spherical shape. Then, to form non-spherical particles it is necessary to direct the 
nanoparticles growth into an anisotropic dimension, breaking the natural tendency for 
isotropic growth. To date, numerous methods regarding AuNR synthesis have been reported, 
as reviewed by Vigderman et al. [15] and P. Zhao et al. [1]. The first reported protocols were 
based in electrochemical and photochemical reduction reactions, both in aqueous surfactant 
media and nanoporous templates [23]. However, such procedure had some weaknesses, such 
as the low total yield of the procedure. In 2001, Murphy’s group developed a seed-growth 
mediated method [24], which was improved in 2003 by El-Sayed’s group [25]. So far, this wet-
chemical synthesis is known to be the most favourable one, since it is possible to prepare 
solutions of well-defined and monodispersed AuNR in high yields.  
The seed-mediated growth method (Figure 2) relies on the chemical reduction of a 
chemical gold source (chloroauric acid, HAuCl4) by a weak reducing agent, ascorbic acid [24]. 
Such reaction leads to the formation of 3-4 nm AuNP, which are used as seeds. Then, these 
seeds are added to a growth solution, containing the chloroauric acid, freshly prepared 
ascorbic acid and CTAB as surfactant. CTAB selectively forms a tightly packed bilayer on the 
side faces of particles, meaning that the ends of the rods stay more exposed, allowing the 
anisotropic growth along the longitudinal axis. As a result, spherical seeds can undergo a 
surfactant-mediated growth leading to AuNR formation. One of the improvements proposed 
by El-Sayed’s group took into account the large amount of spherical AuNP and AuNP with 
other shapes formed as by-products in the first described protocol [25]. To overcome this 
problem, the group proposed the use of borohydride-capped seeds, instead of the citrate-
capped seeds used by Murphy’s group. Moreover, silver nitrate was added to the growth 
solution, in order to control the aspect ratio of AuNR. Such modifications increased the final 
yield of the reaction and led to AuNR with aspect ratios between 1.5 and 4.5, with only 
traces of spherical AuNP. Before use, particles should be washed in order to remove the large 
CTAB excess that remains in solution.  
Figure 2 - Schematic representation of AuNR synthesis process. 
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Gold Nanorods Cytotoxicity and Surface Modifications 
Prior gold nanoparticles wide application in medicine, it is necessary to understand the in 
vivo and in vitro cell viability when cells are exposed with the material. Whereas a multitude 
of studies have already addressed this key point, the results are not consensual, which is 
probably a consequence of the lack of standardized protocols, with well-established 
concentrations of particles and cell types [14, 26, 27]. Therefore, cytotoxicity assays have to 
be performed with the prepared nanoparticles for the intended applications.  
Some works appointed particles size as an important factor for AuNP toxicity, mostly due 
to the increased redox-reactivity found in small particles (dcore < 2 nm) [28, 29]. Y. Pan et al 
[28] have performed a systematic cytotoxicity study of water-soluble AuNP stabilized by 
triphenylphosphine derivatives, with sizes ranging from 0.8 to 15 nm. Particles were 
incubated with four different cell lines, representing the major functional cell types. The 
AuNP cytotoxicity has shown to be highly size-dependent, since smaller particles induced cell 
death. However, cell viability was not affected by the ligand chemistry. Recently, 
Vijayakumar et al. [29], have performed a similar study using citrate-capped AuNP. 
Interestingly, the cell viability test shows two distinguishable cytotoxic effects. The AuNP of 
3 nm, 8 nm, and 30 nm after 24 hours of incubation were cytotoxic, whereas particles of 5 
nm, 6 nm, 10 nm, 17 nm, and 45 nm were non-toxic, even with higher concentrations and 
long-term exposure. With these results, the authors have concluded that AuNP exert only a 
mild toxicity or in some cases no toxicity at all in MCF-7, PC-3, and CHO22 cell lines.  
Besides the size-dependent toxicity reported to spherical AuNP, recent works show 
evidences that AuNR cytotoxicity is independent of particles aspect ratio, but highly 
dependent of its surface chemistry [30, 31].  
The aforementioned seed mediated method for AuNR synthesis uses CTAB as a structure-
directing agent. This surfactant forms a chemisorbed bilayer, which coats the AuNR surface. 
As a result, CTAB bilayer also prevents particles aggregation under certain conditions due to 
the repulsive electrostatic interactions between the cationic groups. Nevertheless, the 
presence of free CTAB molecules have shown clear cytotoxic effects, due to their interactions 
with the cellular membrane, weakening membrane integrity [31].  
To improve biocompatibility and stability in biological media, and then allow biomedical 
applications of AuNR, particles need to be properly purified and functionalized. Therefore, 
several groups have been focussed their work in the development of new processes of surface 
modifications [14, 15], by replacing and/or masking the CTAB adsorbed on AuNR surface.  
The most used methods are schematically represented in Figure 3. 
Method A: A Layer-by-layer (LbL) approach was first suggested by Murphy et al. [32], and 
relies on the successive multilayer coating of anionic and cationic polyelectrolytes on the 
AuNR surface (Figure 3-A). The strategy consists on the adsorption of anionic polyelectrolytes 
such as polyacrylic acid (PAA) or polystyrenesulfonate (PSS) on the positively charged AuNR-
CTAB, due to electrostatic interactions. As a result, the AuNR net charge changes from 
positive to negative, and cationic polyelectrolytes can then be adsorbed. 
Poly(diallyldimethylammonium chloride) (PDDAC) [31] and poly(allylamine hydrochloride) 
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(PAH) [32, 33] are some of the polymers commonly used for cationic coating. This process can 
be repeated multiple times, improving AuNR stability and allowing the incorporation of cargos 
with different charge. Adsorbed polyelectrolytes hinder desorption of CTAB molecules, 
leading to a decrease of AuNR cytotoxicity [33]. Moreover, contrarily to CTAB-coated AuNR, 
polyelectrolyte-coated AuNR displayed an improved solubility in solutions with high salt 
concentration, polar organic solvents and biological media, which is necessary for biological 
applications [15]. For example, AuNR modified with PAA and PAH have shown 90% of cell 
viability after four days, whereas CTAB one reduce the cell viability to 40% [33]. This fact 
confirms that free CTAB molecules are greatly contributing for the observed AuNR 
cytotoxicity and not its charge or size. 
Method B: Replacing CTAB by other molecules, with reduced cytotoxicity, is also possible. 
To do so, some groups have used mesoporous silica to coat AuNR [34–37], resulting in a core-
shell nanoparticles structure (Figure 3-B). The preferred method, an adaptation of Stöber 
method for silica coating, makes use of the CTAB bilayer on AuNR surface as a template. 
Consequently, three-dimensional polymerization of the silica precursor, tetraethyl 
orthosilicate (TEOS), occurs on the surface of CTAB molecules, leading to silica condensation. 
In the end of the process, the surfactant is completely removed by several washes with 
ethanol and through ion change, which can ensure particles non-cytotoxicity. Due to its 
morphology, comprising several mesopores and nanochannels, mesoporous silica is usually 
synonym of high payload of drug/genes, which is very useful for drug delivery systems (DDS) 
[38]. Therefore, besides improving AuNR biocompatibility, such approach empowers AuNR as 
a drug delivery system. Nevertheless, mesoporous silica coated AuNR are described as 
biocompatible, Zhu et al. has reported notable cytotoxicity when those particles were 
incubated with several cell lines [39].  
Figure 3 - Common methods of AuNR surface modification: A-layer by layer; B – silica coating; C – 
displacement of the surfactant by thiol-terminated molecules; D – insertion of hydrophobic 
molecules; E – on-particle polymerization. 
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Method C: One of the standard methods for AuNP modification is based on its high affinity 
with thiol moieties, arising from a strong S-Au bond [40]. This type of linkage is sufficient to 
prepare stable AuNP conjugates. Therefore, they can be easily and directly functionalized on 
its surface with different biomolecules containing sulfur groups, with CTAB being displaced by 
excess of thiolated species, (Figure 3-C). The most common surface ligand is the thiolated 
polyethileneglycol (PEG), which can minimize particles cytotoxicity while improving its 
stability in physiological media [41–43].  
Insertion of hydrophobic molecules within the CTAB bilayer (Figure 3-D) [27] hinders the 
release of CTAB molecules from AuNR surface to the media, thus improving particles 
biocompatibility. As depicted in Figure 3-E, the use of polymerizable surfactants [44] can also 
allow to obtain AuNR with reduced cytotoxicity. These surfactants can polymerize on-
particle, which decreases surfactant desorption from the surface of nanoparticles. 
Consequently, particles became more biocompatible and stable under different processing 
steps as centrifugation or dialysis.  
1.1.2. Gold Nanoparticles as DDS 
The impact of nanotechnology on the development of new drug delivery systems (DDS) is 
a breakthrough, and various types of NP have been developed in order to improve drug 
delivery [45]. NP with encapsulated, dispersed, adsorbed or conjugated drugs, have unique 
characteristics that can improve the drug delivery process. Nanocarriers often enhance the 
drug solubility, leading to rapid dissolution, which results on an improved bioavailability. The 
drug dose needed to achieve therapeutic benefit can be potentially reduced, since the 
delivery is more efficient when nanomaterials are used. Thereby, application of NP as DDS 
could also improve therapeutic efficacy, reduce drug dose and re-dosage needs while 
avoiding the deleterious side effects of drugs. Furthermore, NP size and surface 
characteristics can be easily manipulated to achieve both passive and active drug targeting 
[45]. The therapeutic applications of NP are wide-ranging, such as cancer treatment [46], 
vaccine delivery [47], and gene therapy [48], among others.  
AuNP facile synthesis, easy surface modification and bioconjugation, chemical inertness, 
excellent biocompatibility and low cytotoxicity are characteristics that made these particles 
a proper vehicle for DDS, as recently reviewed by Kumar et al. [49] and Jeong et al. [50]. 
Moreover, their high surface area and ability to be functionalized with a variety of 
biomolecules allow to greatly increase the amount of immobilized biomolecules.  
Nevertheless, the application of AuNP as DDS implies the engineering of its surface, in 
order to provide an effective and stable immobilization of the load to AuNP surface. Upon 
surface modification, particles can be conjugated with several types of molecules such as 
peptides [51], proteins [52], small drugs [53], plasmid DNA (pDNA) or small interfering RNA 
(siRNA) [50]. Drug loading on AuNP can occur by various methods. As aforementioned, one of 
the most used strategies to functionalize AuNP makes use of thiolated species, which strongly 
bind to AuNP surface. Thiolated DNA [54] and thiolated peptides [55] anchor to the particles 
via S-Au bonding, making AuNR biocompatible vehicles for drug and gene delivery. Thiol 
motifs can also be used to act as linker between a desired molecule and AuNP surface. As an 
example, Zandberg et al. [56] developed a photothermal release system, where a linker with 
alkanethiol and oxabicycloheptene motifs were used to tether a fluorescent dye to AuNP 
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surface. While the alkanethiol motif can act like an anchor, the latter is responsible for the 
photoresponsible properties of this system. A temperature above 60ºC-70ºC leads to bond 
breaking of oxabicycloheptene and consequently release of its cargo (Figure 4). 
Another strategy for drug loading is to modify AuNP core with mesoporous silica shell 
(AuNR-SiO2). As stated before, mesoporous silica is highly porous, leading to a high drug 
payload. By instance, Zhang et al. [37] have designed a hybrid strategy taking advantage of 
mesoporous silica and AuNR properties. The group incorporated an anti-cancer drug, 
doxorubicin, within the silica shell and its release was controlled via application of NIR light. 
Monem and colleagues [35] have used a similar approach to load into AuNR- SiO2 and deliver 
doxorubicin both in vitro and in vivo. The formulation was found to possess a very low 
toxicity effect in normal tissue and could target its full damage to cancerous tissues. 
Likewise, Minati et al. [57] incorporated doxorubicin on gold nanoparticles surface by 
adsorption, followed by a LbL deposition of polyelectrolytes. In acidic conditions, such as 
those found in tumours and endocytic vesicles, doxorubicin amino groups are highly 
protonated and the polymeric shell collapses. Consequently, doxorubicin is rapidly released 
at acidic pH, comparing to neutral conditions. These NP were able to deliver its cargo into 
the nuclei of A549 cells, leading to pronounced cytotoxic effects to lung tumour cells. Elbakry 
et al. have successfully designed layer-by layer assembled AuNP for intracellular delivery of 
DNA [58] and siRNA [59]. The strategy was to intersperse the genetic material within PEI 
layers, as shown in Figure 6.  
AuNP also offer the possibility to combine multiple functions, such as drug delivery and 
imaging [14]. Hence, researchers had explored AuNP not only as a therapeutic tool but also as 
an imaging probe, which can give meaningful knowledge about NP fate after administration 
and serve as a theranostic device.  
Figure 4 – Schematic representation of Zandberg’s rational [56].  
Gellan Gum-Coated Gold Nanorods for Drug Delivery Applications 
Sílvia C. Araújo Vieira 
8 
 
When comparing to spherical AuNP, non-spherical nanoparticles may have some 
advantages as a multifunctional DDS. The possibility to absorb light in the NIR region can be 
exploited and confer new functionalities for DDS. For instance, controlled drug release can be 
achieved taking advantage of AuNR photothermal effects. Figure 5 schematically represents 
the aforementioned strategy. When AuNR absorbs NIR light, energy is dissipated as heat, 
which can help the release of drugs that are physically absorbed or chemically conjugated to 
AuNR surface. Following this rational, Wijaya et al. designed a system where two different 
DNA oligonucleotides were separately attached and selectively released from a mixture of 
two different AuNR. The application of different NIR laser, corresponding to the LPB 
maximum wavelengths of each type of AuNR, confers the selectivity to this system [60].  
Figure 6 - Flowchart of Elbakry et al. strategy for the production of 
layer-by-layer assembled AuNP for siRNA delivery [59]. 
Figure 5 - Schematic representation of Wijaya et al. rational. Selective releases were induced by 
selective melting of gold nanorods via ultrafast laser irradiation at the nanorods’ LPB resonance 
peaks. When particles were submitted to an 800 nm irradiation (left), AuNR (blue) melts and 
release its cargo, DNA labelled by FAM (green triangles). Exposure to an 1100 nm irradiation (right) 
melt the nanobones (red), which selectively release DNA labelled with TMR (orange stars). Releases 
were efficient (50−80%) and externally tunable by laser fluence. Released oligonucleotides were 
still functional [60]. 
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Moreover, AuNR were employed to deliver an innate immune activator (5’PPP-single 
stranded RNA, ssRNA) against type A influenza virus [61]. ssRNA were conjugated with AuNR 
via electrostatic interactions and applied in human respiratory bronchial epithelial cells 
infected with the virus. The AuNR optical properties were advantageous for this work, 
enabling the observation of internalized particles by dark field microscopy. By its turn, Guo 
et al. used chitosan-AuNR as a multifunctional system for cell imaging, drug delivery and NIR-
photothermal therapy [5]. AuNR were coated with a chitosan matrix, which was used as a 
reservoir for the loading of cisplatin. The in vitro experiments have shown that modified 
nanoparticles were able to deliver the drug in the intracellular compartment. Moreover, due 
to AuNR optical properties, AuNR can be used as labelling probes, allowing real-time cell 
imaging by dark-field microscopy. In a recent work, Chen et al. [62] described a method to 
stabilize AuNR with polyelectrolytes (PE) and BSA protein to obtain multi-layered AuNR 
(AuNR-PE-BSA). Doxorubicin was then encapsulated into AuNR-PE-BSA by electrostatic 
interactions and particles were successfully used for in vivo combined thermo-and-chemo-
therapy.  
The possibility of combining several functionalities in only one system is really 
advantageous for DDS. Beneficial synergies that can be achieved without the administration 
of adjuvants, the improved control over the system and the possibility to obtain more in-
depth information about the fate of the carriers are absolutely desired under this scope. 
AuNP, including AuNR, are increasingly being used as DDS surpassing other inorganic 
nanoparticles, like quantum dots or carbon nanotubes, mostly due to their biocompatibility 
and inherent physicochemical properties.  
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1.2. Gellan Gum 
Due to their unique properties, biocompatibility, low production costs and widespread 
ability, natural gums are being used in several applications. These polysaccharides started to 
be applied in food industry, as a structuring and gelling agent in a variety of food products 
[63]. Nowadays, they can be found on several personal care products, for example 
toothpastes and sunscreens, and as excipients for pharmaceutical and biomedical purposes 
[64].  
Gums can be extracted from numerous sources, like plant tissues, seeds, seaweeds and 
microorganisms. Among the bacterial polysaccharides, gellan gum (GG) is the most well-
known. GG is a nontoxic, biocompatible and biodegradable anionic heteropolysaccharide 
secreted by the bacteria Sphingomonas elodea (previously Pseudomonas) [65]. Its molecular 
structure is based in one repeating unit consisting of α-L-rahmnose, β-D-glucose and β-D-
glucuronate, in the molar ratios 1:2:1 [67–69]. In the native form, or high acyl form, two 
types of acyl substituents are present: acetyl and L-glyceryl [69]. As shown in Figure 7, both 
substituents are located on the same glucose residue. However, while L-glyceryl is present, 
on average once per repeat, acetyl appears once per two repeating units [70]. Low acyl 
gellan gum is obtained through alkaline hydrolysis of native GG, which removes both of the 
acyl residues [65].  
 
At high temperatures, gellan has a disordered coiled conformation. But as the 
temperature decreases, polymer chains start to fold into double helix structure (Figure 8) 
[71]. At this configuration, gellan can exhibit “weak gel” characteristics, though is not 
considered a true gel. Both forms of gellan form hydrogels in the presence of mono, di- [72], 
[73] and trivalent ions, and gel characteristics are influenced by the presence of acyl groups 
[74]. In high-acyl gellan gum, the acyl residues are located on the periphery of the helix, 
obstructing the polymer chain association. Thus, packing is less effective and the resulting 
gels are soft, elastic and non-brittle. In contrast, low-acyl gellan gum produces firm, non-
Figure 7 - Gellan gum structure. Native or high acyl gellan gum (upper image); low acyl gellan 
gum (image bellow) [108]. 
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elastic, brittle gels since ions can easily link polymer chains and form a branched network. 
Differences between high acyl and low acyl gellan gum are stated on Table 1. Other gel 
properties like gelling temperature, gel strength and rate of gel formation depend on several 
factors of the prepared solution, such as pH value [75], type and concentration of ions [76] 
and presence of sugars [77].  
 
Table 1 - Comparison of High Acyl and Low Acyl Gellan Gum properties [66, 79]. 
 
High Acyl 
Gellan Gum 
Low Acyl 
Gellan Gum 
Molecular weight 1-2x106 Daltons 2-3x105 Daltons 
Solubility Hot water Hot or cold water 
Set temperature 70-80ºC 30-50ºC 
Thermo reversibility Thermo-reversible Heat stable 
 
As a product, GG is approved for food, non-food, cosmetic and pharmaceutical use in 
numerous countries, including the United States and the European Union [53]. Applications of 
GG for tissue engineering [65, 80–83], dental care [83], gene delivery [85, 86] are also being 
studied.  
1.2.1. Gellan Gum in Nanotechnology 
To date, GG has been widely used in pharmaceutical applications, and various strategies 
for regenerative medicine, stomatology and gene transfer technology are under development 
[64]. However, few investigations have reported the use of GG for nanoparticles 
development. In 2008, Dhar et al. [53] reported the synthesis of AuNP using GG as capping 
and reducing agent. These particles have shown a superior stability to pH alterations and 
Decreasing temperature 
Figure 8 - Schematic representation of gradual transformation of GG in aqueous solution, through 
different temperatures. Adapted from [64]. 
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addition of electrolytes, comparing to the particles prepared by the standard methods using 
citrate or borohydride as reducing agent. Additionally, particles were successfully loaded 
with doxorubicin hydrochloride, an anticancer drug, for drug delivery purposes. Later, the 
same group accessed the cellular uptake of gellan gum-reduced AuNP (AuNP-GG) in mouse 
embryonic fibroblast cells and human glioma cell line [86]. After three hours of treatment 
with AuNP-GG, results have shown that cancer cells uptake AuNP-GG, contrarily to fibroblast 
cells. This work also evaluated AuNP-GG cytotoxicity in rats after a treatment of 28 days with 
an orally delivered dose of particles. After the treatment, rats did not show biochemical or 
haematological alterations, meaning that AuNP-GG particles were non-toxic in animals 
following oral administration. In a different study [87], a glycolipid – sophorolipid – was 
successfully conjugated with AuNP-GG and loaded with doxorubicin to increase cytotoxic 
effect against cancer cell lines. Likewise, the same group have extended their process to 
silver NP [88]. Recently, Sivakumar and colleagues used GG to coat magnetic NP [89]. This 
approach led to biocompatible particles with low cytotoxicity, with potential for drug 
delivery applications.  
GG combined with polyethyleneimine (PEI), a widely known transfection agent, have been 
developed for gene delivery purposes [84]. The GG-PEI nanoparticles have shown to enhance 
transfection efficiency and to minimize the cytotoxicity as compared to PEI, or other 
commercial transfection agents. The authors claim that this is due to a partially 
neutralization of PEI positive charge by GG, which also protects plasmid DNA from nucleases 
and serum proteins present in the blood. 
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1.3. Aim of the Project 
After literature overview, it is possible to state that AuNR show a great potential as DDS. 
Their ease of synthesis and functionalization, biocompatibility and optical properties make 
them a promising tool not only as a carrier for drug delivery but also for cell tracking 
applications. Since the preparation of AuNR involves the use of cetyl trimethylammonium 
bromide, a cytotoxic surfactant, their surface modification is essential to render them 
biocompatible. Therefore, several methods including thiol chemistry, shell coating (e.g., 
silica, chitosan) and LbL coating have been proposed.  
 This work aims to develop gellan gum-coated AuNR, to be used as DDS in tissue 
engineering and regenerative medicine approaches.  
Gellan gum is a biocompatible natural gum with great physicochemical properties and has 
been widely used for food, pharmaceutical and biomedical applications. Nevertheless, there 
are only few reports regarding the application of this heteropolysaccharide in 
nanotechnology. To our knowledge, only Dhar’s group [53] has used GG as reducing and 
stabilizing agent to produce gold nanoparticles for further drug loading. Furthermore, no 
specific investigation has been reported regarding on the coating of AuNR with gellan gum 
shell. This shell would assure particles biocompatibility and increase their stability, under 
different conditions. 
Merging the advantages of both compounds AuNR and GG, herein it was designed and 
characterized a novel methodology for AuNR functionalization. The proposed strategy 
involved two steps: i) pre-coating via adsorption of two different polyelectrolytes (PAA and 
PAH) using a LbL strategy, and ii) formation of a GG shell at the gold core surface. To analyse 
the feasibility of this approach, nanoparticles were analysed through different methods, in 
order to assess their optical properties, size, dispersion, surface charge and morphology. To 
validate our particles for further biomedical applications, in vitro studies were performed 
with two different cell-types: SaOS-2, human osteoblast-like cells, and rabbit adipose derived 
stem cells. These analysis aims to determine particles cytotoxicity and to evaluate the 
cellular uptake.  
Even though, the first step of the work was aimed to assess the feasibility of the methods 
for obtaining core-shell structure of AuNR-GG, the second major goal comprised the 
incorporation of a model drug used in bone tissue engineering.  
Recently, some reports highlighted the possibility that AuNP stimulate the osteogenic 
differentiation of mesenchymal stem cells as well as osteoblast-like cell, toward osteoblast 
formation. Yi et al. [90] have reported that 20 nm AuNP induce mechanical stress on the 
mesenchymal stem cells, which activates p38 mitogen-activated protein kinase pathway 
(MAPK) signalling pathway. This signalling pathway regulates the expression of relevant genes 
that induce osteogenic differentiation and inhibits adipogenic differentiation. Zhang et al. 
[91], in a recent work, found that 20 nm and 40 nm AuNP have a beneficial effect on cell 
viability, differentiation and mineralization of mice osteoblasts. These effects were more 
noticeable in cells treated with smaller AuNP. The authors also found that such biological 
effects occur via the ERK/MAPK signalling pathway. In another work, Liu et al. [92] have 
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investigated the size effect of gold nanoparticles on the proliferation, differentiation and 
mineralization of a murine pre-osteoblast cell line, MC3T3-E1, in vitro. After 7 and 14 days of 
culture, proliferation, differentiation, and mineralization of MC3T3-E1 cells was reported, in 
a time- and dose-dependent manner. Better results were observed with smaller particles, 
suggesting that the size may play a role to stimulate the osteogenic differentiation. 
Contrarily, Tsai et al. [26] reported that 10 nm AuNP do not affect osteogenesis and apoptosis 
of MG63 osteoblast-like cells. They observed that the viability, specific nodule-like phenotype 
and gene expression were similar with or without particles. Also, the apoptosis and necrosis 
percentages of the untreated and treated cells after 8 days were similar.  
Therefore, herein it was hypothesised a new methodology to combine AuNR 
biocompatibility, optical properties, drug delivery capacity and regenerative potential. To 
that end, and following the rational of Oliveira et al. [93] and Monteiro et al. [94], 
dexamethasone was loaded inside polyelectrolyte-coated AuNR (AuNR-(PAA PAH)) and GG-
coated AuNR (AuNR-(PAA PAH GG)) in order to compare their feasibility as drug delivery 
systems.  
Thereby, this work assumes a relevant role on the conception of new integrated systems 
of drug delivery and imaging. With this approach, it was possible to understand the 
characteristic of modified AuNR and how they interact with cells, providing important data 
for future studies.  
1.4. Outline 
This document is divided into five chapters. In Chapter 1 – Introduction, a general view 
of the scientific background supporting this project and its objectives is presented. The 
materials, methodologies and equipment are described in Chapter 2 – Materials and 
Methods. Chapter 3 – Results – encloses all the relevant results found during this project. 
The results and their implications are further discussed and analysed in Chapter 4 – 
Discussion. As a final point, the main results are highlighted in Chapter 5 – Conclusions – as 
well as the prospects and future work. 
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Chapter 2 
Materials and Methods 
2.1. Synthesis of Gold Nanorods 
The gold nanorods were synthesized by the seed-mediated growth method [25]. First, a 
gold seed solution was prepared by the borohydride reduction of 0.25 mM HAuCl4 (Sigma-
Aldrich) in an aqueous 0.2 M Cetyltrimethylammonium bromide (CTAB) (Sigma-Aldrich) 
solution. Subsequently, 100 µL seed solution was added to a 21.6 mL growth solution 
containing 0.2 M CTAB, 1.15 mM HAuCl4, 56 mM of HCl (VWR), 2.3 mM ascorbic acid (Sigma-
Aldrich) and 0.23 mM silver nitrate (Sigma-Aldrich). The solution was aged for 24 hours at 
30ºC to ensure the complete formation of AuNR. CTAB excess was removed by three cycles of 
centrifugation (5,000rpm, 8,000rpm, 10,000rpm and 13,500rpm for 15 minutes each) and 
particles were dispersed in Milli-Q water. The concentration of gold nanorods was determined 
at the LPB peak maximum using molar extinction coefficient ε= 5.109 M-1 cm-1 [95]. 
2.2. Surface Functionalization 
2.2.1. Functionalization with PAA and PAH 
Purified particles were modified using a layer-by-layer approach. Briefly, a solution of 
1.60 nM of particles was added, drop-wise and under vigorous stirring, to an aqueous solution 
of poly(acrylic acid sodium salt) (PAA) (4 g/L, Mw 5 100 Sigma-Aldrich; 6 mM NaCl). PAA 
adsorption was allowed to proceed for 2 hours, at room temperature and under stirring. PAA 
excess was removed by centrifugation and particles re-dispersed in Milli-Q water. The process 
was repeated with poly(allylamine hydrochloride) (PAH) (4g/L, Mw 15,000 Sigma-Aldrich; 
6mM NaCl). After, particles were washed by centrifugation. 
2.2.2. Functionalization with GG 
Low acyl gellan gum (Gelzan™ CM Gelrite®, Sigma-Aldrich) solution was prepared with a 
concentration of 0.5% (w/v), in ultra-pure water. To allow its dissolution, GG solution was 
heated up to 90ºC, under vigorous stirring. Then, AuNR modified with PAA and PAH were 
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added, drop-wise, and the solution was continuously heated and stirred for 5 minutes. The 
mixture was cooled down at room temperature, being stirred overnight. Finally, particles 
were washed by centrifugation.  
2.3. Characterization of nanoparticles 
2.3.1. Spectrophotometric analysis (Optical properties)  
All AuNR solutions were appropriately diluted and absorbance from 1100 to 200 nm 
wavelength was determined using a UV-Vis spectrophotometer (Shimadzu, UV-1601). UV-Vis 
analysis was used to confirm the rod shape of AuNR and to determine its concentration. The 
extinction coefficient, ε =5.109 M-1 cm-1 was used to determine the particles concentration, 
according to the Beer-Lambert equation (1) [95]. 
𝐴𝑏𝑠LPB = 𝜀𝑙𝑐      (1) 
where AbsLPB corresponds to the maximum absorbance value of LPB, l corresponds to the 
length of the cuvette (commonly 1 cm) and c represents the particles concentration. 
2.3.2. Surface Potential 
Surface potential was measured with Zetasizer (Malvern, NanoZS). Samples of AuNR-
CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG), dispersed in ultra-pure water, were read 
three times and surface charge was calculated using the Smoluchowski equation. 
2.3.3. Morphological characterization 
To confirm particles rod-shape and the GG coating, transmission electron microscopy 
(TEM) and scanning electron microscopy (SEM) analysis were performed. Samples were 
prepared by placing a drop of each type of particles solution above a copper grid and let it 
dry completely, under a light source. TEM images were acquired using Jeol JEM 1400 and 
performed at IBMC-INEB, Porto.  
SEM samples preparation: samples were dried at approximately 50ºC, either on glass 
watch or on a mica substrate. The samples dried on glass watch were then glued on carbon 
tape. Images were taken using a NanoSEM – FEI Nova 200 (FEG/SEM) with an EDAX – Pegasus 
X4M (EDS/EBSD). 
2.4. Particles Stability  
2.4.1. Ionic Strength 
Stability under different electrolytic concentrations was evaluated by addition of a NaCl 
solution to AuNR-CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG) particles. Fixed quantities 
of 2M NaCl were added to 2 mL solutions of each particles type, in order to have the desired 
final salt concentrations of 1 mM, 5 mM, 10 mM, 20 mM, 50 mM, 0.1 M and 0.5 M. Solutions 
were properly mixed and left overnight at room temperature. UV-Vis spectra were acquired 
24 hours after salt addition.   
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2.4.2. pH 
In order to evaluate particles stability at different pH comprised between 4 and 10, fixed 
amounts of hydrochloric acid (HCl), for pH below 6, or sodium hydroxide (NaOH), for pH 
above 6, were added to 2 mL solutions of particles. Solutions were mixed and left overnight 
at room temperature. UV-Vis spectra were acquired 24 hours after pH modifications.   
2.5. Dexamethasone Incorporation 
Dexamethasone-loaded nanoparticles were prepared by mixing AuNR coated with PAA and 
PAH with a dexamethasone solution (6.66 nM, Sigma-Aldrich) for 3 hours, at room 
temperature in the dark. Then the solution was directly mixed with a GG solution (0.5% w/v), 
at 90ºC under vigorous stirring for 5 minutes. This mixture was cooled down until room 
temperature and stirred overnight, in the dark. GG excess was removed by centrifugation. 
2.5.1. Fourier Transform Infrared Spectroscopy (FTIR) 
In order to detect surface changes motivated by dexamethasone presence, FTIR spectra 
were recorded on an IR-Prestige-21 (Shimadzu, Japan) controlled by IRsolution software. 
Particles solutions were dried at 45ºC during overnight, and then crushed with potassium 
bromide (Sigma-Aldrich) to prepare a tablet. Spectra were taken in the range 500-4500 cm-1. 
2.6. In vitro studies 
2.6.1. Cell culture 
SaOS-2 cells (Sarcoma osteogenic) were cultured in Dulbecco’s modified Eagle’s medium 
low glucose (Sigma-Aldrich) supplemented with 10% fetal bovine serum (Alfagene) and 1% 
antibiotic-antimycotic (Alfagene). Cells were grown until confluence at 37ºC and 5% CO2 
atmosphere, with changing of media every three days. Rabbit adipose derived stem cells 
(ASC) were isolated using the group well-established protocols and culture in α-MEM cell 
culture media.  
2.6.2. Cell viability 
Assessment of the potential effect of AuNR on cell viability was performed using a 
standard 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-
tetrazolium (MTS) viability test. All materials were processed under sterile conditions. 
Particles sterilization was achieved by passing the different solutions through a 0.22 µm 
filter. 
The MTS viability test on SaOS-2 [96] was performed after contact of cells with different 
types of nanoparticles: AuNR-CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG). 
SaOS-2 cells were grown as monolayers as described above. After several passages, 
confluent cells were detached from the flasks using TrypLE™ Express Enzyme (Life 
Technologies) and a diluted suspension was centrifuged at 1200 rpm for 5 minutes. SaOS-2 
cells were seeded in each well of a 24-well TCPS plate (three replicates per sample) at a 
Gellan Gum-Coated Gold Nanorods for Drug Delivery Applications 
Sílvia C. Araújo Vieira 
20 
 
density of 25 x 103 cells/well and cultured for 24 hours at 37ºC in a 5% CO2 atmosphere. Then, 
cells were incubated with 200 µL of each type of nanoparticles, making up a final 
concentration of 0.05 nM/well. The medium was changed every three days, followed by an 
addition of new particles. Cells without particles were used as a control. The MTS test was 
performed after 3, 6 and 9 hours and 1, 2, 3, 7 and 14 days of culture at 37ºC and 5% CO2 
atmosphere. Culture medium was removed and cells were washed twice with phosphate 
buffered saline solution (PBS) at pH 7.4. Subsequently, 350 mL of a mixture containing serum-
free culture medium without Phenol Red and MTS (CellTiter W 96 AQueous One Solution Cell 
Proliferation Assay kit; Promega) at a ratio of 5:1 was added to each well. Optical density 
(OD) was measured at 490 nm using a microplate reader (Synergy HT, Biotek) after 3 hours 
incubation at 37ºC and 5% CO2 atmosphere. The percentage of cell viability was calculated by 
normalization with the mean OD value obtained for the control. All tests were performed in 
triplicate (n= 9). 
Similar in vitro cytotoxicity studies were performed using rabbit ASC. The cells were 
incubated with AuNR-(PAA PAH GG) and cell viability was quantified after 1, 7 and 14 days. 
The procedure was similar as the one for SaOS-2, but 96-well plates were used with a cell 
density of 4 x 103 cells/well. This experiment was performed with n=6. 
 
2.6.3. Nanoparticles Uptake 
2.6.3.1. Optical Microscopy 
SaOS-2 cells were cultured in the same conditions used for MTS assay, but on the top of 
TCPS cover slips.  Cells were grown during, 3, 6 and 9 hours and 1, 2, 3, 7 and 14 days. After 
each time point, cell culture medium was removed and cells were washed twice with PBS 
buffer. Then, cells were fixed with 10% formalin for 15 minutes, at room temperature. After, 
formalin was removed; cells were washed with PBS and stored in PBS, protected from light at 
4ºC, until staining.  
Cells were stained with 4,6-Diamidino-2-phenyindole, dilactate (DAPI) and Phalloidin–
Tetramethylrhodamine B isothiocyanate (phalloidin – TRITC) in order to mark nuclei and the 
cytoskeleton, respectively. To do so, cells were permeabilized with a 0.2% solution of 
Triton™ X-100 (Sigma-Aldrich) for 5 minutes. Then, cells were washed twice with PBS and a 
solution of phalloidin – TRITC (Sigma – Aldrich) diluted 1:200 in PBS was added. After 45 
minutes at room temperature, the dye was removed and cells were washed again, with PBS. 
At last, cells were incubated at room temperature with a solution of DAPI (Sigma – Aldrich) 
diluted in PBS (1:1000), for 5 minutes. After another washing step, cover slips were mounted 
with Vectashield (Vector Laboratories) on microscope lamellae, and sealed with nail polish. 
Samples were finally analysed by fluorescence microscopy and dark field microscopy. The 
dark-field and fluorescence images were acquired in fast sequence with a wide-field inverted 
fluorescence microscope (Nikon, model Ti-E). Dark-field imaging was enabled through a 
dedicated dry dark-field condenser providing an illumination aperture between 0.8 and 0.95 
enabling imaging with a 40x objective with collection numeric aperture of 0.75 (CFI Plan 
Fluor, Nikon). Fluorescence excitation is provided by a high performance broadband Xenon 
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light source integrated with a fast excitation filter wheel coupled via a liquid light guide to 
the microscope. 
2.6.3.2. Transmission Electron Microscopy 
Rabbit ASC were seeded in 24-well culturing plates using a density of 25 x 103 cells/well. 
After an overnight, AuNR-(PAA PAH GG) were added to culture medium at a concentration of 
0.05 nM/well. During 14 days, the medium was changed every three days, followed by a 
particles supplement. After the treatment, cells were detached and centrifuged and the cell 
pellet was washed with PBS. Cells were centrifuged and the new pellet was fixed with 2.5% 
glutaraldehyde. The Histology and Electron Microscopy Service of IBMC-INEB Porto performed 
post-fixation work. For SaOS-2, IBMC facility performed a post-fixation work on cells fixed as 
described for optical microscopy. 
2.7. Statistical analysis and Software 
Cell viability data was averaged and mean ± standard deviation was plotted. The data was 
statistically compared by a “Two-Away ANOVA” analysis and complemented with Bonferroni 
post-tests. In all statistical evaluations, p<0.05 was considered as statistically significant. 
Statistical analysis was performed using GraphPad Prism 6 software. UV-Vis data were treated 
and analysed using the Origin9 software (OriginLab).  
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Chapter 3 
Results 
3.1. Synthesis and Characterization of Gold Nanorods 
The UV-Vis spectrum (Figure 9, black line) exhibits a typical AuNR sample stabilized with 
CTAB in water, where the peaks at 510 nm and 820 nm correspond to the transverse and 
longitudinal resonances, respectively. With the goal of removing the excess of CTAB, which is 
cytotoxic for cells, the AuNR were washed three times and re-dispersed in purified water. 
Figure 9 represents the UV-Vis spectra of as-prepared AuNR (red line) and purified AuNR 
(black line). From figure it is possible to observe that after three washing steps, the amount 
of free CTAB decreases, as noticed by a decrease of absorbance in a range of 200-300 nm. 
The purified AuNR exhibit a zeta potential of +35.9 ± 1.3 mV, due the positive charge of 
CTAB.  
The TEM and SEM images (Figure 10) of AuNR revealed that the nanorods have an average 
length of 47 ± 10 nm and 10 ± 2 nm in diameter with an aspect ratio of approximately 4.7.  
Figure 9 - UV-Vis spectra of AuNR before (black line) and 
after (red line) the washing step. 
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3.2. Surface Functionalization 
In the aim of masking and displacing the CTAB layer to make AuNR more biocompatible 
and stable, the particles were capped with two layers of polyelectrolytes following the LbL 
method. Based on electrostatic interactions between the different compounds, the negative 
poly(acrylic acid) (PAA) and a positive poly(allylamine hydrochloride) (PAH), were 
alternatively adsorbed on the AuNR-CTAB surface, as represented in Figure 11. 
 
 
The successful multilayer coating was confirmed via zeta potential measurements at each 
step of the process since the charge of the particles were in agreement with the net charge 
of each compounds. The AuNR are positively charged with ζ = +35.9 ± 1.3 mV, due to the 
presence of cationic CTAB bilayer on the surface. After the reaction with anionic PAA, the 
zeta potential was negative, ζ = -52.4 ± 3.9 mV, changing to a positive value of ζ = +43.5 ± 
2.8 mV after the functionalization with cationic PAH. 
Figure 12-A exhibits the UV-Vis spectra before and after the polyelectrolyte 
functionalization. For clarification, it is worth mention that normalization of absorption 
spectra at the maximum of the longitudinal resonance has been performed. The exchange of 
capping agent, by successive deposition of PAA and PAH, does not lead to aggregation, since 
Figure 10 – A: TEM images of AuNR with and 250 000x magnification; B: SEM images of 
AuNR with 200 000x magnification. 
Figure 11 – Schematic representation of layer-by-layer approach for 
AuNR modification. 
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a narrow LPB is observed in each UV-Vis spectrum. Figure 12-B shows a representative TEM 
image of AuNR-(PAA PAH). Due to the small dimensions of polyelectrolyte coating, it is not 
distinguishable on TEM images. 
3.3. Gellan Gum Coating 
Finally, the AuNR-(PAA PAH) were coated with gellan gum (GG) as schematically 
represented in Figure 13. To confirm the successfully adsorption of GG on particles surface, 
AuNR-(PAA PAH GG) were characterised by UV-Vis spectrometry, zeta potential and electron 
microscopy analyses.  
 
 
 
 
 
 
 
 
The UV-Visible spectra of AuNR-(PAA PAH) and AuNR-(PAA PAH GG) are shown in Figure 
14-A. After GG coating, the LPB underwent a red-shift of 8 nm, which is a result of the 
change in the surrounding environment of particles. Moreover, the presence of GG is 
confirmed via a band located at 260 nm. As shown in Figure 14-B, GG present a band at this 
wavelength. Zeta potential measurements also have confirmed the modification of particles 
Figure 12 - A: UV-Vis spectra of AuNR, AuNR coated with PAA and AuNR-(PAA PAH); B: TEM image of 
AuNR-(PAA PAH) with a magnification of 250 000X. 
Figure 13 – Schematic representation of AuNR-(PAA PAH) 
modification with GG. 
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surface charge, caused by the incorporation of negatively charged GG. Therefore, after this 
coating, particles acquired a negative charge of -32.8 ± 4.9 mV. 
 
TEM and SEM analysis were performed to confirm the formation of a GG shell around 
AuNR. TEM images (Figure 15-A and Figure 15-B) clearly show, contrarily to the 
polyelectrolyte-coated AuNR (Figure 12-B), the presence of a GG shell around individual 
AuNR. Shell thickness was measured as 6.8 ± 1.5 nm. SEM was used to assess the surface 
morphology of the hybrid nanoparticles. However, the resolution of SEM equipment used on 
this study was not sufficient to fulfil this aim (Figure 15-C). Backscattered electrons analysis 
(Figure 15-D), which can discriminate different compounds based on their atomic number, 
indicates that gold is the core of particles.  
Figure 15 – A: TEM image of AUNR-(PAA PAH GG) particles with 150 000X magnification; B: TEM image of 
AuNR-(PAA PAH GG) with 250 000X magnification; C: SEM image of AuNR-(PAA PAH GG); D: Backscatter 
electron analysis of AuNR-(PAA PAH GG). 
Figure 14 – A: UV-Vis spectra of AuNR-(PAA PAH) (red line) and AuNR-(PAA PAH GG) (black line); B: UV-
Vis spectra of AuNR-(PAA PAH GG) (black line) comparing to the spectrum of a 0.25% w/v GG solution 
(red line). 
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3.4. Stability Studies 
Particles behaviour on different settings was determined based on their UV-Vis spectrum, 
since LPB is very sensitive to particle aggregations. 
Ionic Strength: 
The ionic strength was varied by addition of different volume of a solution of 2 M of NaCl. 
The final salt concentration in the AuNR modified and unmodified solutions were in a range of 
concentrations from 1 mM to 0.5 M.  
As-prepared AuNR were shown to be the most susceptible to variations of salt 
concentration (Figure 16-A). Indeed, as soon as the salt concentration increased to 1 mM, a 
significant change of the longitudinal plasmon band, intensity decrease and widening of the 
band, is observed, resulting from the gold nanoparticles aggregation. Interestingly, for AuNR-
CTAB a maximum state of aggregation was noticed for a concentration of 10 mM, 
corresponding to a lower absorbance value (Figure 16-D), but it was partially reversed with 
higher salt concentrations. AuNR-(PAA PAH) appeared to be more stable than AuNR-CTAB, but 
changes on UV-Vis spectra were also detected (Figure 16-B). When NaCl concentration 
Figure 16 – UV-Vis spectrometry analysis of ionic strength influence on particles stability. Defined 
concentrations of NaCl were added to solutions of (A) AuNR-CTAB, (B) AuNR-(PAA PAH) and (C) AuNR-
(PAA PAH GG) and the respective UV-Vis spectra were acquired after an overnight; (D) Absorbance as a 
function of salt concentration. For each type of particle, absorbance was measured at maximum 
wavelength found on particles without salt. 
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reached 20 mM, LPB became wider and the drop of intensity is clearly noticed (Figure 16-D). 
Those effects became more and more evident with higher concentrations, showing that 
particles aggregate under these conditions. The presence of GG at NP surface improved the 
ionic strength stability up to 0.1 M (Figure 16-C), since the LPB remained basically at the 
same position with a slight absorbance decrease (Figure 16-D). At 0.5 M, the particles start to 
aggregate, highlighted by a decrease of absorbance amplitude, broadness of LPB and a red- 
shift of approximately 13 nm.  
pH effect:  
The pH was modified by addition of hydrochloric acid (HCl) for pH below 6 and by 
addition of sodium hydroxide (NaOH) for pH above 6.  
The improved stability of AuNR with GG was also noticed when pH was changed. Both 
AuNR-CTAB and AuNR-(PAA PAH) were susceptible to basic pH (Figure 17-A and B). In both 
cases, the LPB became wider and absorbance drop occurs, compared to the spectrum at pH 
6. The pH effect was more discernible in AuNR-(PAA PAH) (Figure 17-B, green and pink line), 
where LPB almost disappeared. Acidic pH did not change the shape of LPB, but a shift on its 
Figure 17 - UV-Vis spectrometry analysis of pH influence on particles stability. Defined concentrations of 
HCl and NaOH were added to solutions of (A) AuNR-CTAB, (B) AuNR-(PAA PAH) and (C) AuNR-(PAA PAH 
GG) in order to get acidic and basic conditions, respectively. The respective UV-Vis spectra were 
acquired after an overnight; (D) Absorbance as a function of pH. For each type of particle, absorbance 
was measured at maximum wavelength found on particles at pH=6. 
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position and decrease on its intensity was noticed (Figure 17-D, pink and yellow line). On 
AuNR-CTAB, acidic pH led to a decrease in LPB intensity followed by a red-shift of 5 nm 
(Figure 17-A, black and red lines). On its turn, the same conditions, caused a blue-shift on 
LPB of AuNR-(PAA PAH) of 11 nm and 20nm at pH=4 and pH=2, respectively. However, the UV-
Vis spectra of AuNR-GG (Figure 17-C) show narrow LPB for the different pH, highlighting that 
the presence of GG lead to improve AuNR stability. Although no obvious change by UV-Vis was 
observed (Figure 17-D, green line), at acidic pH we clearly observed by eye that the particles 
start to flocculate.  
3.5. In vitro Studies 
3.5.1. Cell viability 
For each surface modification step, cytotoxic assays were performed in order to evaluate 
the biocompatibility of AuNR-CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG). Firstly, two 
different concentrations of 0.04 nM and 0.08 nM of particles per well were tested, in order to 
evaluate possible cytotoxicity over SaOS-2 cells. An MTS assay was performed to determine 
cell viability after 24 hours of incubation in presence of particles. The obtained absorbance 
values were normalized by the control sample (i.e. without presence of particles). Then, 
graph represents the percentage of viability comparing to control.  
Figure 18 represents the cell viability results obtained for both concentrations. Whereas it 
is clearly observed that AuNR-CTAB are cytotoxic, for 0.04 nM and 0.08 nM of AuNR-(PAA PAH) 
and AuNR-(PAA PAH) it was observed no deleterious effect on the SaOS-2 cells viability. No 
difference was noticed between the two conditions for modified particles and the control. 
Considering the data obtained from the in vitro studies and other values found on literature 
[26, 33], the chosen concentration for further studies was 0.05 nM/well.  
Cell viability was then assessed culturing SaOS-2 cells with different types of particles, for 
different time points: 3 hours, 6 hours, 9 hours, 24 hours, 72 hours, 7 days and 14 days. As it 
Figure 18 – Cell viability of SaOS-2 after 24 hours, with different types of particles at 0.08 nm and 0.04 nM. 
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is shown in Figure 19, cell viability in presence of AuNR-CTAB decreased along the 14 days 
of study. After 6 hours of incubation, cell viability start to decrease comparatively to control, 
reaching only 81% of the viability observed in control cells. In the end of the study period, 
cell viability was only 5%, confirming the deleterious effect of CTAB on SaOS-2 viability. The 
difference on cell viability between control and cell incubated with particles start to be 
significant after 6 hours, with p<0.01. From 9 hours up to 14 days, the difference was also 
significant but with a p<0.001. On the other hand, after 14 days of incubation, the presence 
of AuNR-(PAA PAH) and AuNR-(PAA PAH GG) did not affect cell viability significantly, and cell 
viability was always superior to 93%.  
Considering that AuNP cytotoxicity varies between different cell types, cell viability was 
also performed on rabbit adipose derived stem cells. Cell viability was assessed after 1, 7 and 
14 days of incubation with AuNR-(PAA PAH GG) (Figure 20). Surprisingly, cell viability was 
higher in all the tested time-points, confirming the non-toxic nature of AuNR-(PAA PAH GG). 
Figure 19 - Cell viability of SaOS-2 cell line cultured with AuNR, AuNR-(PAA PAH) and AuNR-(PAA PAH 
GG) for 14 days, comparing to control; Upper panel it is a general view of all data. The inferior one 
represents the same data but organized by particles type. From left to right: cell viability when 
incubated with AuNR, AuNR-(PAA PAH) and AuNR-(PAA PAH GG). Results expressed as an average ± 
standard deviation. (n=9, * p<0.01; **p<0.001). 
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3.5.2. Internalization of AuNR 
Taking advantage of optical properties of AuNP, particles internalization was analysed by 
fluorescence microscopy with dark-field. The nuclei were stained with DAPI and the 
cytoskeleton with Phalloidin-TRITC, to allow the observation of cell morphology under 
fluorescence microscopy, after incubation with the AuNR-(PAA PAH GG). Next, scattering and 
fluorescence images were simultaneously acquired with dark-field microscopy and 
fluorescence microscopy (Figure 21). The red parts show the cytoskeleton and the blue parts 
the nuclei (Figure 21-A and Figure 21-C). By its turn, the bright spots in dark-field images 
(Figure 21-B and Figure 21-D) result of the light scattering of AuNR.  
Analysing the dark-field images, one can see that no brightness is noticed in control 
samples (Figure 21-B). However, in samples incubated with AuNR-(PAA PAH GG) these bright 
spots were found, meaning that modified AuNR were internalized by SaOS-2 cells after 48 
hours (Figure 21-D). From fluorescence images, it can be seen that there is a small 
difference in cell morphology between the two conditions, control (Figure 21-A) and AuNR-
(PAA PAH GG) (Figure 21-C). Although spread cells were found in both conditions, comparing 
to untreated cells, the number of round shape cells appeared to be higher when cells were 
cultured with the particles. 
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Figure 20 - Cell Viability of ASC cultured with AuNR-(PAA PAH GG) for 1, 7 and 
14 days, comparing to cell viability of ASC without particles. Results expressed 
as an average ± standard deviation. (n=6). 
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AuNR-(PAA PAH GG) internalization after 14 days of culturing was also evaluated by TEM, 
both on SaOS-2 and rabbit ASC. Internalization was observed in both conditions, as shown in 
Figure 22 and Figure 23, respectively. Particles were localised inside cytoplasmic vesicles, 
forming aggregates. Nevertheless, it is important to notice that the vesicles observed were 
different. While in SaOS-2 particles were found mostly in multi-layered vesicles, particles 
were surrounded by one-layered vesicles when uptaken by ASC. Thence, intracellular traffic 
after AuNR-(PAA PAH GG) internalization may differ among the tested cells.  
 
2 4 
Figure 21 - Fluorescence microscopy of SaOS-2 incubated without particles (A) and with AuNR-(PAA 
PAH GG) (C) for 48 hours. Red areas represent the cytoskeleton stained by Texas Red – X phalloidin 
and blue areas the nuclei, stained with DAPI; dark filed microscopy of the same samples (B) and (D) 
respectively. 
Figure 22 - TEM images of SaOS-2 after 14 days of incubation with AuNR-(PAA PAH GG) at 0.05 nM. 
AuNR-(PAA PAH GG) aggregated within cytoplasmic vesicles, shown with arrows. Magnification of 
40 000X (left) and 60 000X (right). 
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3.6. Incorporation of Dexamethasone 
The incorporation of dexamethasone was done right after the PAH coating, by adding 
particles to a dexamethasone solution. These particles were then mixed with a GG solution 
with final concentration of 0.25% w/v, in order to obtain AuNR-(PAA PAH GG) loaded with 
dexamethasone. As before, modified particles were washed by centrifugation. 
The aforementioned method was performed using AuNR-(PAA PAH) and AuNR-(PAA PAH 
GG). However, the first ones aggregated after the first centrifugation cycle, precluding their 
use in further experiments. Figure 24-A shows the UV-Vis spectra of AuNR-(PAA PAH) with 
dexamethasone before the washing and after the first two steps of the cycle. Since particle 
aggregation was noticed during the lower speeds, the cycle was not completed.  
As it is shown in Figure 24-B, the UV-Vis spectrum of particles that were covered with a 
GG layer did not change in a substantial way during the washing cycle. Hence, covering 
particles with a GG layer led to particles with more stability, which did not aggregate right 
after centrifugation.  
Figure 24 – UV-Vis spectra of AuNR-(PAA PAH) (A) and AuNR-(PAA PAH GG) (B) after loading with 
dexamethasone. In both graphs, the black line is the UV-Vis spectra of particles before washing; while 
the red line represents the UV-Vis spectra of particles after one wash cycle. 
Figure 23 - TEM images of rabbit ASC after 14 days of incubation with AuNR-(PAA PAH GG) at 0.05 
nM. AuNR-(PAA PAH GG) aggregated within cytoplasmic vesicles, shown with arrows. Magnification 
of 1 200X (left) and 50 000X (right). 
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Although it was possible to evaluate particles stability after the drug loading process, its 
efficiency was not as straightforward. Electronic absorption spectroscopy was not suitable, 
since UV-Vis spectra of GG and Dexa overlap in the wavelengths between 226 nm and 281 nm, 
as it is shown in Figure 25. 
FTIR spectroscopy was also carried out in order to assess on dexamethasone loading. In 
addition to the partial overlap of AuNR-(PAA PAH GG) spectra with the one corresponding to 
dexamethasone, drug concentration inside particles may be below the detection limits of the 
technique (Figure 26).  
Figure 25 – UV-Vis spectra of Dexamethasone (black line) and Gellan Gum (red line). 
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Figure 26 - FTIR spectra of (A) dexamethasone; (B) AuNR-(PAA PAH GG); (C) 
dexamethasone loaded AuNR-(PAA PAH GG). 
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Chapter 4 
Discussion 
Due to their unique and remarkable properties, gold nanoparticles caught attention of 
researchers in diverse areas. As aforementioned, biocompatibility, ease of synthesis, 
chemical inertness and their optical and photothermal properties are some of the key 
features that made them so interesting to the scientific community. As alternative to 
spherical nanoparticles, AuNR, an anisotropic shape of AuNP, are commonly used for 
biomedical purposes [14]. Additionally to AuNP advantages, AuNR can be tuned in size in 
order to absorb in the NIR region of the spectra. Since tissues do not absorb in this region of 
the spectra, AuNR can be used both for imaging purposes, for controlled drug release 
approaches, with NIR triggered release, and for hyperthermia therapies.  
 In the present work, it has been reported the development of a novel method for AuNR 
functionalization, taking advantage of stabilizing and biocompatible properties of gellan gum. 
Firstly, well-dispersed AuNR were successfully synthesized by a seed-mediated growth 
method [25], using CTAB as surface passivant. To prepare AuNR with a LPB located above 800 
nm, hydrochloric acid was added to the growth solution. Indeed, it has been observed that 
the synthesis of AuNR in acidic pH lead to the formation of longer particles, resulting in a 
shift of the LPB in the NIR [97].  
The as-prepared AuNR presented in their UV-Vis spectrum two bands, located at 510 nm 
and 820 nm, corresponding to the transverse and longitudinal plasmon, respectively. TEM 
images revealed homogeneous AuNR with an average length of 47 ± 10 nm and an aspect ratio 
of approximately 4.7.  
 The preparation of biocompatible nanomaterials is essential for their use in biomedical 
applications. However, the AuNR synthesis method implies the use of CTAB, which has 
cytotoxic effects. Even though centrifugation partially removes free CTAB molecules, is still 
necessary to modify AuNR surface. 
AuNR-(PAA PAH GG) were then prepared in two sequential steps. Firstly, the gold 
nanorods were covered with a thin bilayer of polyelectrolytes to improve their stability and 
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to mask the CTAB on the AuNR surface. In the process of AuNR synthesis, the CTAB forms a 
cationic bilayer at the surface of AuNR and generate a positive charge of +35 mV. Therefore, 
based on the LbL method, alternative layers of opposite charged polyelectrolytes can be 
adsorbed on the positive AuNR via electrostatic interactions. Herein, polyelectrolyte-
modified AuNR were achieved by sequential adsorption of the negatively charged PAA, 
followed by the adsorption of positively charged PAH. Accordingly, the addition of PAA 
changes the surface charge from positive to negative values (ζ= -52.4 ± 3.9 mV), and flipped 
again to positive values after PAH coating (ζ= 43.5 ± 2.8 mV). The UV-Vis spectra of both 
AuNR-PAA and AuNR-(PAA PAH) remained similar to the AuNR-CTAB one, suggesting that after 
polyelectrolyte modification the particles remain stable and well-dispersed in purified water. 
Then, the PAH-modified AuNR were added to a low acyl gellan gum solution. Due to the 
negative charge (pKa=3.1) of GG in purified water, GG may adsorb on the positively charged 
AuNR-(PAA PAH) via electrostatic interaction. However, dry gellan gum is not miscible in 
water at room temperature. To allow its dissolution, 0.5% w/v GG in solution need to be 
previously heated at 90ºC before the addition of the particles [71]. The mixture was then 
stirred during 5 minutes at 90ºC to allow a good dispersion of the particles within the 
polysaccharide and then left overnight at room temperature. Upon decreasing the 
temperature, gellan gum may form a hydrogel-like structure around the particles. 
Centrifugation steps were then performed to remove the excess of GG, and resulting 
nanoparticles were characterized by different techniques to confirm the formation of the GG 
shell on the AuNR surface. By UV-Vis analysis it was possible to observe that the LPB 
underwent a red-shift, arising probably to a change of the surrounding environment during 
the adsorption process. Moreover, UV-Vis spectrum of the hybrids exhibits a new band 
located at 260 nm, attributed to the presence of the GG.  The AuNR-(PAA PAH GG) have a 
negative zeta potential of -32.8 ± 4.9 mV, indicating both the presence of the anionic GG and 
good stability of the nanoparticles in aqueous solution. Zeta potentials higher than +25 or 
below -25 mV are considered to be the threshold values for stable colloidal suspensions. Our 
process of coating has shown the successful preparation of AuNR-(PAA PAH GG) core-shell 
structure, where individual AuNR are coated by homogeneous GG shell around 7 nm, as 
revealed by the TEM image. Unfortunately, results from SEM analyses were not conclusive, 
due to the low resolution of the equipment. 
When designing nanoparticles for biomedical applications, stability under different pH 
and ionic conditions should be considered. To assess this question, we measured and 
compared the UV-Vis spectra of AuNR-CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG) when 
dispersed in a range of pH and electrolytic conditions. Due to sensitivity of LPB to particle 
aggregation, it is possible to analyse and compare particles stability under different 
conditions. The aggregation is noticed via shifts, tailing, broadening and decrease of intensity 
of LPB.  
The ionic strength was evaluated by addition of a solution of NaCl in a range of 
concentration from 1 mM to 0.5 M. At low salt concentration, AuNR-CTAB have tendency to 
easily aggregate. Interestingly, one expected to observe a more obvious aggregate state for 
higher ionic strength, but the absorbance amplitude of LPB increases and the width of the 
LPB decreased, suggesting that particles are more stable. This results have already been 
observed under other conditions [98, 99] and explained as following: at low salt 
concentration, the Cl− anions bind electrostatically to the positively charged AuNR-CTAB. As a 
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result, particles experience a charge screening of the electrostatic repulsion, which leads to 
their aggregation. At higher concentrations of salt, Cl− concentration is sufficient to form a 
second electronic layer, minimizing the aggregation of AuNR-CTAB.  
AuNR-(PAA PAH) has shown a superior stability than AuNR-CTAB for low ionic strength. 
Whereas, AuNR-CTAB aggregate from 1 mM, the polyelectrolyte-modified nanoparticles 
remained stable up to 20 mM and then underwent a progressive aggregation as the ionic 
strength increases. 
Gellan gum heteropolysaccharide has shown to improve the stability of the AuNR in a 
wider range of salt concentration, from 1 mM to 0.1 M. The UV-Vis spectra of all conditions 
remain similar with a slight intensity decrease as the concentration increase. At 0.5 M, the 
amplitude decrease and the wideness and red-shift of the LPB are more pronounced, 
suggesting that the particles get closer to form aggregate.  
The other interesting aspect to study is related to particles stability under different pH 
conditions. Both AuNR-CTAB and AuNR-(PAA PAH) are unstable under basic pH, as noticed by 
a change of the LPB, whereas AuNR-(PAA PAH GG) kept stable.  Moreover, as the pH increase, 
the aggregation stages were more pronounced for the both positively charged particles, i.e. 
AuNR-CTAB and AuNR-(PAA PAH). Indeed, by increasing the pH, the molecules adsorbed on 
the AuNR are deprotonated. PAH exhibit a pKa around 8.6 [33]. At pH<pKa, the 
polyelectrolyte is positively charged due to the protonation of the amino group in –NH3
+, 
resulting to repulsion between particles that maintain a colloidal stability. However, at 
pH>8.6, the deprotonated amino group –NH2 has no charge, leading to a decrease of charge 
repulsion between particles. Therefore, aggregation occurs and is more significant as the pH 
increases.  On the other hand, GG exhibits a pKa around 3.06 [100]. At pH>3.1, the gellan 
gum is negative due to the presence of group COO-. Under basic pH, the negative repulsion 
promotes nanoparticles stability. However, under acid pH, the particles should have 
aggregated, involving a change of LPB. The UV-Vis spectra measured at pH 2 and 4 exhibit a 
narrow LPB suggesting that the particle are dispersed in solution and not aggregate. With 
eye, we could observe that the particles flocculate. Gellan gum in general is pH-sensitive and 
in acidic pH it has the tendency to form a gel [75]. Herein, it has been hypothesized that 
instead to promote aggregation when decreasing the pH, the GG interacts and embedded the 
particles in a matrix that protect them against aggregation. 
Biological environment requires working at pH around 7-8 and high ionic strength. 
Therefore, the synthesized hybrid materials have shown more promising features than the 
polyelectrolytes-modified nanoparticles and the AuNR-CTAB, showing the utility to surface 
coat the particles with a hydrogel layer.  
Once confirmed the ability to functionalize nanoparticles with GG and the improvement 
of the proposed system under conditions close to the ones present in physiological media, it 
has been also studied how particles can interact with cells, in vitro. Recent studies have 
shown that AuNP may promote osteogenic differentiation in some cell types [91–93]. 
Following this idea, along with the rational used by Oliveira et al. [93] and Monteiro et al. 
[94], it has been attempted to use AuNR-(PAA PAH GG) as drug delivery system to promote 
osteogenic differentiation of stem cells. Therefore, cell viability and internalization capacity 
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in two different cell types has been investigated. Firstly, SaOS-2, a human osteoblast-like cell 
line commonly used for osteoblastic models [101], were used to test the biocompatibility of 
AuNR-CTAB, AuNR-(PAA PAH) and AuNR-(PAA PAH GG). Then, and considering the final aim of 
this work, cell viability on rabbit adipose derived stem cells, which have osteogenic 
differentiation capacity [102], was investigated after incubation with AuNR-(PAA PAH GG) for 
1, 7 and 14 days. Cell viability was assessed using an MTS assay. The MTS tetrazolium 
compound is bio-reduced by cells into a coloured formazan product, that is soluble in tissue 
culture medium [103]. NADPH or NADH, produced by dehydrogenase enzymes in metabolically 
active cells, presumably performs such conversion. Then, the quantity of formazan is directly 
proportional to the number of living cells in culture. 
Since literature is not coherent regarding the appropriate concentration of particles [26], 
two different concentrations of 0.04 and 0.08 nM/well were tested in SaOs-2 cultures. 
Contrarily to surface modified AuNR, AuNR-CTAB have induced considerable cytotoxicity after 
24 hours of incubation. However, no significant differences were noticed in cell viability 
between the both conditions. Considering other reported data [33], a concentration of 
particles of 0.05 nM/well was used on cell viability studies.  
When incubated with SaOS-2, AuNR-CTAB were found to be highly cytotoxic, with 
significant differences relative to control after 6 hours of incubation, when cell viability 
decreased to 81%. Under these conditions, cell viability has continuously decreased and after 
14 days of culture reached only 5%. By its turn, cell viability was not affected by the presence 
of both AuNR-(PAA PAH) and AuNR-(PAA PAH GG), along the 14 days of study. Such results are 
in accordance with the ones reported by Alkilany et al. [33], who associated AuNR 
cytotoxicity to the free CTAB molecules. Although centrifugation of particles was performed 
three times, CTAB still remained on AuNR-CTAB solutions. Further centrifugations are not 
recommended, though, to not compromise particles stability [98]. The obtained results 
corroborate that over coating the AuNR with polymers substantially reduces particles 
cytotoxicity, since CTAB molecules are masked and do not directly interact with cell 
membranes. Regarding cell viability of rabbit ASC, unexpectedly, AuNR-(PAA PAH GG) 
promoted cell viability as compared to ASC without particles. Nevertheless, it is necessary to 
repeat once these experiments, in order to obtain statically significant results and confirm 
this observation.  
Due to their small size, nanoparticles are easily uptaken by cells. Previous studies 
suggested receptor-mediated endocytosis as the mechanism of cellular uptake for 
biomolecules within the size range of AuNR [33]. This mechanism is based on the recognition 
of proteins present on the serum-containing media by receptors of cellular membrane. When 
included in serum-containing media, media proteins, mostly BSA [33], adsorb on particles 
surface, changing their surface charge to values similar to the media alone. Thus, particles 
can be recognized by the cellular receptors and consequently be internalized.  
Particle internalization was firstly evaluated with fluorescence and dark field microscopy 
in SaOS-2 incubated with AuNR-(PAA PAH GG) for 48 hours. Due to the optical properties of 
AuNR, particles could be distinguished as bright spots when analysed by dark field 
microscopy, allowing their detection without any additional labelling method. After 48 hours 
of incubation, it was possible to observe such bright areas inside cells, indicating particles 
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internalization, as shown in Figure 21-D. However, due to equipment constrains it was not 
possible to acquire images at higher magnification, that would possible allow a more specific 
localization of particles within cells. Fluorescence microscopy was used to localise and obtain 
cell morphology, by means of cytoskeleton and nuclei staining. One interesting observation is 
that samples incubated with particles had more round-shape cells comparing to control. 
Although cell viability was similar between cells culture with and without particles, it would 
be interesting to determine and quantify apoptosis at a single cell level. TUNEL technology, 
which labels DNA strand breaks associated to apoptosis phenomena, could be used to obtain 
such information. By this way, it would be possible to understand if the observed round-shape 
is due to programmed cell death or to other cellular response to AuNR-(PAA PAH GG).  
To overcome the low magnification of dark field, and gain deeper insights on how 
particles behave inside cells, cells were analysed by TEM. On SaOS-2, after 14 days of 
culture, particles were found inside cells, aggregated within multilamellar vesicles, 
presumably late endosomes. Likewise, on rabbit ASC, particles were also internalized, but 
were found inside cytoplasmic vesicles with only one membrane. Such difference can possibly 
be a result of alternative endocytosis routes, which differ within cell types. Thereby, it would 
be interesting to study how AuNR-(PAA PAH GG) are internalized and understand their 
intracellular route once inside cells. This could be achieved using a combination of several 
methods such as flow cytometry, fluorescence and electron microscopy techniques, as 
reported by Shapero et al. [104]. Although Shapero’s work was focused on understanding the 
behaviour of silica nanoparticles in human cells, the multidisciplinary rational can be applied 
for AuNR-(PAA PAH GG). High-resolution membrane capacitance measurements could also 
give interesting data regarding this issue [105]. This method is based on the measurement of 
plasma membrane capacitance fluctuations, which are due to fusion and fission of secretory 
and other vesicles. The measurements can be performed on a daily basis, which would allow 
a continuous study of particles-cell interactions.  
As mentioned before, one of the great potential of AuNR-(PAA PAH GG) is for intracellular 
drug delivery. Considering a previous work of our group, that successfully used dendrimers for 
intracellular delivery of dexamethasone, we tried to apply such rational to our GG-coated 
AuNR. Therefore, dexamethasone, a glucocorticoid widely used as supplement in osteogenic 
media, was adsorbed onto particles surface for further delivery inside cells. The 
incorporation was performed with AuNR-(PAA PAH) and AuNR-(PAA PAH GG) particles, but 
only GG capped particles remain stable after the washing process, as seen by UV-Vis analysis. 
Such observation corroborates the improved stability of AuNR-(PAA PAH GG) as compared to 
AuNR-(PAA PAH) observed before. Unfortunately, it was not possible to confirm the presence 
of dexamethasone on particles. UV-Vis cannot be used as a detection method since GG and 
dexamethasone absorb in the same region of the spectra, between 226 and 281 nm. FTIR 
analysis was also inconclusive, which could be due to a low concentration of dexamethasone 
on samples. Moreover, GG and dexamethasone spectra are partially overlapped, hindering 
the possibility of undoubtedly attest dexamethasone presence in particles. Then, further 
studies are needed to study dexamethasone loading on AuNR-(PAA PAH GG), in future. 
Possible approaches for further studies can include the utilization of labelled dexamethasone, 
either with a fluorescent dye [106] or radioactive labelling [107], or through NMR analysis.  
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Chapter 5 
Conclusions 
In summary, herein it has been reported a new method for gold nanorods (AuNR) surface 
modification, using natural and biocompatible gellan gum (GG). 
A layer-by-layer approach was used to firstly modify AuNR, with aspect ratio of 4.7, with 
polyelectrolytes and then with GG. TEM images have confirmed the formation of a 7 nm GG 
shell around individual AuNR. UV-Vis analysis and a zeta potential of -32.8 ± 4.9 mV have 
proved AuNR stability on ultra-pure water at neutral pH. The potential of these particles as a 
new tool for biomedical purposes was highlighted by their enhanced stability under a range of 
pH and ionic strengths, which also shows the feasibility of using GG as stabilizing agent.  
Likewise, in vitro studies have corroborated the possibility of applying GG-coated AuNR 
on biomedical applications. No cytotoxicity has been found when GG-coated AuNR were 
incubated with SaOS-2 and rabbit adipose stem cells at a concentration of 0.05 nM/well, up 
to 14 days of culturing. Due to AuNR optical properties, it was possible to evaluate particles 
internalization by dark-field microscopy, without any additional label probe. The results 
indicated that cells are able to uptake the particles, which was also confirmed by TEM. Once 
inside cells, particles aggregate within cytoplasmic vesicles, behaviour previously reported 
for other types of gold nanoparticles. Nevertheless, vesicles morphology was not similar 
between the two cell types, which may be a result of different intracellular traffic routes.  
One of the intended applications for the method here reported is intracellular drug 
delivery of dexamethasone. When compared to polyelectrolyte-coated AuNR, GG-coated 
AuNR have shown a higher stability after dexamethasone loading step. Although promising, it 
was not possible to confirm the effective drug loading.  
Therefore, further experiments are needed to confirm and optimize the drug delivery 
potential of GG-coated AuNR. Following the rational previously proved by our group, one of 
the applications for the proposed surface-coated particles could be stem cell differentiation, 
namely osteogenic, by intracellular drug delivery of drugs or growth factors. To investigate 
this hypothesis, further studies would be performed to compare the differentiation extent of 
cells incubated with dexamethasone loaded GG-coated AuNR and with the standard 
osteogenic media. In the future, it would be also interesting to combine the drug delivery 
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potential of these particles with the remarkable optical properties of AuNR. Such 
multifunctional system would allow not only to deliver drugs on intracellular compartment, 
but also track cells in real time, without further labelling. 
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